For the drug program, Andrew Dahlem, PhD, chief of clinical pharmacology and senior research professor of medicine at IU School of Medicine will chair the committee and Richard Taylor, PhD, professor of chemistry and biochemistry at the University of Notre Dame and director of the Molecular Therapeutics Program for the Indiana CTSI, will co-lead the Think Tank pharmaceutical program.

• Navigator: Padma Portonovo (CTSI)
• Chair:  Andy Dahlem (adahlem@iu.edu)  (IUSM)
• Co-Chair: Rich Taylor (rtaylor@nd.edu)  (ND)
• Regulatory representative:  Chris Caldwell (csego@iu.edu) (CTSI)
• Standing academic members :
  • Alan Palkowiz (apalkow@iu.edu)  (IUSM & IBRI & TREAT-AD)
  • Tim Richardson (timorich@iu.edu)  (IUSM & TREAT-AD)
  • Zhong Yin-Zhang (zhang-zy@purdue.edu) (PU)
  • Yvonne Lai (yvonne.lai@anagin.com) (IUB)
  • Mark Kelley (mkelley@iu.edu)  (IUSM, IU Simon Cancer Center CDDD)
  • Brian Blagg (bblagg@nd.edu) (ND, Director Warren Family Center for Drug Discovery and Development)
  • Ramaswamy Subramanian (subram68@purdue.edu) (Purdue, Director Bindley Bioscience Center)
• Business School Representative: Todd Saxton (tsaxton@iu.edu) (Kelley school)
• Standing industry member:
  • Jay McGill (jmcgill@indianabiosciences.org) (IBRI)
    

• Indiana Center for Biomedical Innovation (ICBI)
• Concepts to Clinic Project Development Team
• TL1 Postdoctoral Fellowship, Innovation-Entrepreneurship Track
• For applications specific to Alzheimer’s Disease and Cancer:
  TREAT-AD Center for Alzheimer’s Disease Drug Discovery
  IU Simon Comprehensive Cancer Center (IUSCCC) Cancer Drug Discovery & Development (CDDD) Working Group Platform